Loading people...
Juan-Pablo Mas is a distinguished Partner at Action Potential Venture Capital, a firm dedicated to investing in transformative early-stage biotech, digital health, and life sciences companies.
Juan-Pablo Mas primarily invests in early-stage companies within the biotech, digital health, and broader life sciences sectors, focusing on innovations that address critical healthcare needs.
Juan-Pablo Mas works as a Partner at Action Potential Venture Capital.
Juan-Pablo Mas is a Partner at Action Potential Venture Capital, a bioelectronic medicine fund backed by GlaxoSmithKline, based in Palo Alto, California. Prior to venture investing, he led research, development, and strategy within Medtronic's CardioVascular Division, where he generated over 30 patents and was named the 2008 Inventor of the Year. He also served on the global brand strategy team at Eli Lilly to launch the cardiovascular drug Effient, and later joined the founding team at Lightstone Ventures. Mas currently represents his firm on the boards of multiple neurotechnology portfolio companies, including SetPoint Medical, Cala Health, and Saluda Medical, while previously overseeing a public exit with CVRx. He holds an MBA and a Master of Science in Electrical Engineering from Stanford University, and his current investment focus centers on advancing therapeutic medical devices and bioelectronic neuromodulation technologies.
Juan-Pablo Mas stands as a distinguished Partner at Action Potential Venture Capital, a firm renowned for its strategic investments in the burgeoning fields of biotech, digital health, and life sciences. In his capacity, Juan-Pablo is instrumental in shaping the firm's investment thesis, identifying visionary founders, and providing crucial support to companies poised to revolutionize healthcare. His expertise lies in discerning the potential of early-stage ventures that leverage cutting-edge science and technology to address unmet medical needs and improve patient lives.
At Action Potential Venture Capital, Juan-Pablo Mas primarily focuses on investment opportunities within the biotech sector, including novel therapeutics, diagnostics, and platform technologies. He also has a keen interest in digital health solutions that enhance patient engagement, streamline clinical workflows, and improve healthcare delivery through data-driven insights. Furthermore, his portfolio extends to broader life sciences innovations, encompassing areas like medical devices, genomics, and personalized medicine. Juan-Pablo's approach is characterized by a deep understanding of scientific rigor combined with a sharp business acumen, enabling him to evaluate complex technologies and market dynamics effectively.
Prior to his role at Action Potential Venture Capital, Juan-Pablo Mas cultivated a robust career background that equipped him with a comprehensive perspective on the healthcare and investment landscapes. While specific details of his early career are not publicly detailed, his trajectory likely involved significant experience in either scientific research, pharmaceutical development, or a prior venture capital role focused on healthcare. This foundational experience underpins his ability to not only identify promising scientific breakthroughs but also to guide companies through the intricate stages of development, regulatory approval, and market penetration. His commitment to fostering innovation is evident in his active engagement with portfolio companies, offering strategic guidance and leveraging his extensive network to accelerate their growth.
Juan-Pablo Mas is recognized for his commitment to backing companies that demonstrate both scientific excellence and strong commercial viability. While specific notable investments are often confidential in the early-stage venture capital world, his work at Action Potential Venture Capital consistently targets disruptive technologies that promise to redefine standards of care. He seeks out teams with exceptional leadership and a clear vision for impact, understanding that successful ventures are built on both brilliant ideas and strong execution. Through his strategic leadership and insightful investment decisions, Juan-Pablo Mas continues to play a vital role in advancing the mission of Action Potential Venture Capital to fund the future of healthcare.
